+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hand Foot Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hand Foot Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Onchocerciasis - Pipeline Insight, 2025 - Product Thumbnail Image

Onchocerciasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Burns - Pipeline Insight, 2025 - Product Thumbnail Image

Burns - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Wrinkles - Pipeline Insight, 2025 - Product Thumbnail Image

Wrinkles - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Becker Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Becker Muscular Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
From
Hearing Loss- Pipeline Insight, 2025 - Product Thumbnail Image

Hearing Loss- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-Induced Diarrhea - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Heavy Metal Poisoning - Pipeline Insight, 2025 - Product Thumbnail Image

Heavy Metal Poisoning - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hemolytic Disease Of The Fetus And Newborn - Pipeline Insight, 2025 - Product Thumbnail Image

Hemolytic Disease Of The Fetus And Newborn - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Herpes Keratitis - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Keratitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hospital Acquired Candida Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Hospital Acquired Candida Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Hyperopia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperopia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Scoliosis - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic Scoliosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Immune-Mediated Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Immune-Mediated Depression - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Inclusion Body Myositis- Pipeline Insight, 2025 - Product Thumbnail Image

Inclusion Body Myositis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Inguinal Hernia - Pipeline Insight, 2025 - Product Thumbnail Image

Inguinal Hernia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Intestinal Mucosal Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Intestinal Mucosal Injury - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more